1. Home
  2. SHO vs NVAX Comparison

SHO vs NVAX Comparison

Compare SHO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHO
  • NVAX
  • Stock Information
  • Founded
  • SHO 1995
  • NVAX 1987
  • Country
  • SHO United States
  • NVAX United States
  • Employees
  • SHO N/A
  • NVAX N/A
  • Industry
  • SHO Hotels/Resorts
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SHO Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • SHO Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • SHO 1.7B
  • NVAX 1.3B
  • IPO Year
  • SHO 1995
  • NVAX 1995
  • Fundamental
  • Price
  • SHO $8.99
  • NVAX $7.12
  • Analyst Decision
  • SHO Hold
  • NVAX Buy
  • Analyst Count
  • SHO 8
  • NVAX 5
  • Target Price
  • SHO $9.56
  • NVAX $16.60
  • AVG Volume (30 Days)
  • SHO 2.8M
  • NVAX 5.1M
  • Earning Date
  • SHO 08-06-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • SHO 4.00%
  • NVAX N/A
  • EPS Growth
  • SHO N/A
  • NVAX N/A
  • EPS
  • SHO 0.10
  • NVAX 2.97
  • Revenue
  • SHO $922,708,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • SHO $7.67
  • NVAX $56.85
  • Revenue Next Year
  • SHO $3.45
  • NVAX N/A
  • P/E Ratio
  • SHO $91.64
  • NVAX $2.37
  • Revenue Growth
  • SHO N/A
  • NVAX 25.92
  • 52 Week Low
  • SHO $7.45
  • NVAX $5.01
  • 52 Week High
  • SHO $12.41
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • SHO 55.68
  • NVAX 57.25
  • Support Level
  • SHO $8.70
  • NVAX $6.54
  • Resistance Level
  • SHO $9.08
  • NVAX $6.90
  • Average True Range (ATR)
  • SHO 0.23
  • NVAX 0.29
  • MACD
  • SHO 0.02
  • NVAX 0.06
  • Stochastic Oscillator
  • SHO 84.17
  • NVAX 92.52

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: